HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+14.9%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$272M
AUM Growth
+$272M
(+4.9%)
Cap. Flow
-$12.8M
Cap. Flow
% of AUM
-4.69%
Top 10 Holdings %
Top 10 Hldgs %
27.33%
Holding
177
New
29
Increased
50
Reduced
55
Closed
31
Top Buys
| 1 |
Viridian Therapeutics
VRDN
|
$4.25M |
| 2 |
Advanced Micro Devices
AMD
|
$2.19M |
| 3 |
Celldex Therapeutics
CLDX
|
$2.17M |
| 4 |
Ferguson
FERG
|
$2.15M |
| 5 |
Mineralys Therapeutics
MLYS
|
$2.03M |
Top Sells
| 1 |
Albertsons Companies
ACI
|
$4.15M |
| 2 |
GE Vernova
GEV
|
$3.07M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$3.03M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$2.1M |
| 5 |
Bausch Health
BHC
|
$2.03M |
Sector Composition
| 1 | Healthcare | 37.62% |
| 2 | Technology | 22.09% |
| 3 | Industrials | 8.52% |
| 4 | Financials | 6.08% |
| 5 | Consumer Discretionary | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intuit
INTU
$186B
| $2.57M | 0.94% | 3,263 -600 | -16% | -$473K |
|
27
Revolution Medicines
RVMD
$7.1B
| $2.5M | 0.92% | 68,048 -5,704 | -8% | -$210K |
|
28
NVIDIA
NVDA
$4.24T
| $2.48M | 0.91% | 15,700 +1,100 | +8% | +$174K |
|
29
Quanta Services
PWR
$56.3B
| $2.42M | 0.89% | 6,400 -1,700 | -21% | -$643K |
|
30
Arcellx
ACLX
$3.85B
| $2.35M | 0.86% | 35,714 -11,782 | -25% | -$776K |
|
31
Agios Pharmaceuticals
AGIO
$2.19B
| $2.33M | 0.86% | 70,127 +26,022 | +59% | +$865K |
|
32
Meta Platforms (Facebook)
META
$1.86T
| $2.29M | 0.84% | 3,100 -100 | -3% | -$73.8K |
|
33
Visa
V
$683B
| $2.28M | 0.84% | 6,427 +300 | +5% | +$107K |
|
34
Cytokinetics
CYTK
$4.23B
| $2.27M | 0.83% | 68,652 +23,903 | +53% | +$790K |
|
35
Mastercard
MA
$538B
| $2.25M | 0.83% | 4,000 +300 | +8% | +$169K |
|
36
3M
MMM
$82.8B
| $2.19M | 0.81% | 14,400 +900 | +7% | +$137K |
|
|
37
Advanced Micro Devices
AMD
$264B
| $2.19M | 0.8% | +15,400 | New | +$2.19M |
|
|
38
Celldex Therapeutics
CLDX
$1.47B
| $2.17M | 0.8% | +106,553 | New | +$2.17M |
|
|
39
Ferguson
FERG
$46.4B
| $2.15M | 0.79% | +9,878 | New | +$2.15M |
|
|
40
GE Vernova
GEV
$167B
| $2.12M | 0.78% | 4,000 -5,800 | -59% | -$3.07M |
|
41
Booking.com
BKNG
$181B
| $2.07M | 0.76% | 357 | – | – |
|
42
Cogent Biosciences
COGT
$1.69B
| $2.03M | 0.75% | 283,186 +3,513 | +1% | +$25.2K |
|
|
43
Mineralys Therapeutics
MLYS
$1.03B
| $2.03M | 0.75% | +150,138 | New | +$2.03M |
|
44
Synopsys
SNPS
$112B
| $2M | 0.73% | 3,900 +800 | +26% | +$410K |
|
45
Lyft
LYFT
$6.73B
| $1.98M | 0.73% | +125,800 | New | +$1.98M |
|
46
Apogee Therapeutics
APGE
$2.17B
| $1.96M | 0.72% | 45,052 +1,862 | +4% | +$80.9K |
|
47
Cleveland-Cliffs
CLF
$5.32B
| $1.94M | 0.71% | +255,600 | New | +$1.94M |
|
48
Amphenol
APH
$133B
| $1.88M | 0.69% | 19,000 -3,900 | -17% | -$385K |
|
49
MasTec
MTZ
$14.3B
| $1.87M | 0.69% | 11,000 -5,300 | -33% | -$903K |
|
|
QXO
50
QXO Inc
QXO
$13.6B
| $1.82M | 0.67% | 84,500 -19,000 | -18% | -$409K |
|